TAS0612, a Triple Inhibitor for RSK, AKT, and S6K, Is a Promising Anti-Myeloma Agent Regardless of Types of Cytogenetic/Genetic AbnormalityHaruya Okamoto,Shinsuke Mizutani,Taku Tsukamoto,Yoko Katsuragawa-Taminishi,Reiko Isa,Kentaro Mizuhara,Ayako Muramatsu,Yuka Kawaji-Kanayama,Takahiro Fujino,Yuji Shimura,Junya KurodaBLOOD(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要